John H Kimbrough

17PUBLICATIONS
20CO-AUTHORS
Medical infection agents (incl. prions)Infectious agentsNanotoxicology, health and safetyMedical bacteriologyCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Sep 09, 2026
Impact of PBP3 insertions and β-lactamase-encoding genes on the susceptibility of Escherichia coli isolates belonging to high-risk clones against aztreonam-avibactam and comparator agents.

|Aug 20, 2026
Evaluation of cefiderocol trailing and other unclear susceptibility testing endpoints for Acinetobacter spp.

|Jul 08, 2026
Reduced Activity of Triazole Antifungal Agents Against Aspergillus tubingensis From a Global Collection of Genomically-Characterized Aspergillus Section Nigri Clinical Isolates (2020-2023).

|Apr 30, 2026
Determination of frequency of spontaneous resistance for gepotidacin and levofloxacin against a collection of gram-positive and gram-negative organisms.

|Dec 05, 2025
Activity of aztreonam-avibactam, cefiderocol, and cefepime-taniborbactam against a global collection of genetically characterized metallo-β-lactamase-producing Enterobacterales.

Mariana Castanheira, John H Kimbrough, Gina M Morgan

|Oct 13, 2025
Activity of cefiderocol against Pseudomonas aeruginosa from the USA and Europe (2020-2023) with difficult-to-treat resistance phenotype, including those nonsusceptible to recently developed β-lactam/β-lactamase inhibitor combinations: results from the SENTRY antimicrobial surveillance program.

John H Kimbrough, Maura H Karr, Sean T Nguyen

Pageof 3

Frequent Collaborators

13 joint publications

Mariana Castanheira

8 joint publications

Rodrigo E Mendes

8 joint publications

Helio S Sader

4 joint publications

Marisa Winkler